IOBT
Income statement / Annual
Last year (2023), IO Biotech, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, IO Biotech, Inc.'s net income was -$86.08 M.
See IO Biotech, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$756,000.00 |
$540,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$756,000.00 |
-$540,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$67.83 M
|
$46.99 M
|
$30.15 M
|
$8.46 M
|
$7.94 M
|
| General & Administrative
Expenses |
$23.61 M
|
$24.44 M
|
$11.08 M
|
$1.68 M
|
$1.98 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$23.61 M
|
$24.44 M
|
$11.08 M
|
$1.68 M
|
$1.98 M
|
| Other Expenses |
$0.00 |
$0.00 |
-$26.54 M |
-$1.99 M |
-$781,000.00 |
| Operating Expenses |
$91.44 M |
$71.42 M |
$41.23 M |
$10.15 M |
$9.91 M |
| Cost And Expenses |
$91.44 M |
$71.42 M |
$41.23 M |
$10.15 M |
$9.91 M |
| Interest Income |
$5.88 M |
$1.41 M |
$361.00 |
$26.00 |
$6.00 |
| Interest Expense |
$0.00 |
$302,000.00 |
$361,000.00 |
$26,000.00 |
$6,000.00 |
| Depreciation &
Amortization |
$215,000.00
|
$540,000.00
|
$2,000.00
|
$10.15 M
|
$9.91 M
|
| EBITDA |
-$91.23 M
|
-$69.34 M
|
-$67.45 M
|
$0.00
|
-$824,000.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$6.21 M
|
$1.24 M
|
-$26.58 M
|
-$1.90 M
|
-$830,000.00
|
| Income Before Tax |
-$85.23 M |
-$70.19 M |
-$67.81 M |
-$12.04 M |
-$10.74 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$852,000.00 |
$1.27 M |
$68,000.00 |
$26,000.00 |
$6,000.00 |
| Net Income |
-$86.08 M |
-$71.46 M |
-$67.88 M |
-$12.07 M |
-$10.75 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.98 |
-2.48 |
-2.36 |
-0.42 |
-0.37 |
| EPS Diluted |
-1.98 |
-2.48 |
-2.36 |
-0.42 |
-0.37 |
| Weighted Average Shares
Out |
$43.54 M
|
$28.82 M
|
$28.82 M
|
$28.82 M
|
$28.82 M
|
| Weighted Average Shares
Out Diluted |
$43.54 M
|
$28.82 M
|
$28.82 M
|
$28.82 M
|
$28.82 M
|
| Link |
|
|
|
|
|
